Ascentage Pharma Group International
AAPG | NASDAQ
$15.89
+$0.03 (+0.19%)
Sep 22, 2026, 9:34 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 298.88M | 334.13M | 233.7M | 156.9M | 823.75M | 79.28M | 142.7M | 104.86M | 104.86M | 14.95M | 12.97M |
Cost of Revenue | 48.01M | 68.69M | 21.65M | 14.03M | 15.06M | 12.39M | 18.15M | 11M | 11M | 739K | 2.59M |
Gross Profit | 250.86M | 265.45M | 212.05M | 142.88M | 808.69M | 66.89M | 124.55M | 93.86M | 93.86M | 14.21M | 10.38M |
Operating Income | -743.95M | -640.85M | -553.98M | -566.79M | 187.98M | -532.07M | -340.57M | -424.91M | -424.91M | -434.92M | -434.92M |
Interest Income | 35.59M | 49.78M | 3.61M | 1.43M | n/a | n/a | 32.41M | 4.86M | 4.86M | 3.55M | 3.55M |
Pretax Income | -794.51M | -638.72M | -585.31M | -558.15M | 162.9M | -533.26M | -399.6M | -443.59M | -443.59M | -416.12M | -374.38M |
Net Income | -807.68M | -639.96M | -590.77M | -568.43M | 163M | -523.29M | -402.35M | -441.46M | -441.46M | -391.21M | -391.21M |
Selling & General & Admin | 316.01M | 318.79M | 237.47M | 206.5M | 176.63M | 201.8M | 174.66M | 164.01M | 164.01M | 95.63M | 95.63M |
Research & Development | 678.8M | 587.52M | 528.56M | 503.17M | 444.08M | 397.16M | 309.81M | 371.55M | 371.55M | 383.25M | 383.25M |
Other Expenses | n/a | n/a | n/a | n/a | -2K | n/a | -19.36M | -16.8M | -16.8M | -31.67M | -31.67M |
Operating Expenses | 994.82M | 906.3M | 766.03M | 709.66M | 620.7M | 598.96M | 465.12M | 518.76M | 518.76M | 447.21M | 447.21M |
Interest Expense | 26.52M | 25.79M | n/a | n/a | 28.04M | 20.28M | 75.78M | 26.39M | 26.39M | 8.37M | 8.37M |
Selling & Marketing Expenses | n/a | n/a | 137.79M | 106.36M | 89.64M | 112.07M | 83.32M | 78.71M | 78.71M | 23.87M | 23.87M |
Cost & Expenses | 1.04B | 974.99M | 787.68M | 723.69M | 635.76M | 611.35M | 483.27M | 529.76M | 529.76M | 566.43M | 394.65M |
Income Tax Expense | 13.47M | 1.4M | 5.51M | 10.36M | 69K | -9.9M | 2.75M | -2.12M | -2.12M | -24.91M | -24.91M |
Shares Outstanding (Basic) | 93.31M | 92.6M | 85.37M | 78.09M | 74.01M | 72.51M | 17.64M | 16.48M | 16.48M | 15.91M | 15.91M |
Shares Outstanding (Diluted) | 93.31M | 92.6M | 85.4M | 78.09M | 74.01M | 72.51M | 17.64M | 16.48M | 16.48M | 15.91M | 15.91M |
EPS (Basic) | -8.68 | -6.92 | -6.92 | -7.28 | 2.20 | -7.20 | -45.28 | -26.80 | -26.80 | -24.56 | -24.56 |
EPS (Diluted) | -8.68 | -6.92 | -6.92 | -7.28 | 2.20 | -7.20 | -45.28 | -26.80 | -26.80 | -24.56 | -24.56 |
EBITDA | -701.08M | -598.95M | -514.02M | -528.45M | 229.59M | -492.67M | -250.94M | -412.63M | -412.63M | -405.56M | -405.56M |
EBIT | -743.95M | -640.85M | -553.98M | -566.79M | 187.98M | -532.07M | -304.74M | -417.19M | -417.19M | -407.76M | -407.76M |
Depreciation & Amortization | 42.88M | 41.9M | 39.97M | 38.33M | 41.6M | 39.4M | 53.8M | 4.56M | 4.56M | 2.2M | 2.2M |
Add to Watchlist
Select watchlists to add or remove AAPG